Engineering self-propelled tumor-infiltrating CAR T cells using synthetic velocity receptors
Inventors & their inventions
Axial: https://linktr.ee/axialxyz
Axial partners with great founders and inventors. We invest in early-stage life sciences companies such as Appia Bio, Seranova Bio, Delix Therapeutics, Simcha Therapeutics, among others often when they are no more than an idea. We are fanatical about helping the rare inventor who is compelled to build their own enduring business. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company. We are excited to be in business with you — email us at info@axialvc.com
T-cells exhibit low and high migration phenotypes depending on cell density in 3D collagen gels. At high density, T-cells secrete cytokines like IL5, TNFa, IFNg, and IL8 that shift cells to a high migration state.
The authors used this by engineering "velocity receptors" (VRs) that bind these cytokines and signal through their receptors, pushing CAR T cells into a highly migratory state even at low density.
VR-CAR T cells showed greater infiltration and anti-tumor effects compared to regular CAR T cells alone in mouse models of pancreatic, lung, and ovarian cancer. VR-CAR T cells penetrated deep into tumor cores whereas regular CAR T cells remained largely at the periphery. In an ovarian cancer model, VR-CAR T cell therapy significantly increased mouse survival compared to CAR T alone. This demonstrates that enhancing migration signaling via receptors that take advantage of T cell-secreted cytokines can improve CAR T cell infiltration and efficacy against solid tumors. With their highly modular VELOCIREPTORS, they can generate >30K different types of self-propelled CAR-T cells designed to infiltrate solid tumors. Testing 5 in mouse models of pancreatic/ovarian/lung cancer, three cancers with poor survival rates. The VR approach pushes CAR T cells into a highly migratory phenotype to facilitate tumor infiltration.